Navigating the area of end-of-life care and access to medications like Pentobarbital in New South Wales, NSW, requires a careful comprehension of the intricate legal framework. Currently, this powerful sedative does not have a recognized place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not routinely prescribed by medical pr